Primary dysmenorrhea
Conditions
Interventions
Sponsors
Universidade Federal do Rio Grande do Norte
Universidade Federal do Rio Grande do Norte
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Age between 18 and 45 years; medical diagnosis of primary dysmenorrhea according to Guideline No. 34539; mean pain equal to or greater than 4 on the Visual Analogue Scale of Pain; periodic pain of at least 3 menstrual cycles in a row; having a regular menstrual cycle of 28 to 32 days; no pelvic inflammatory disease; history of head trauma, epilepsy, endometriosis, current pregnancy, chronic abdominal pain unrelated to the menstrual cycle; fibroids; inflammatory bowel syndrome; irritable bowel syndrome; major abdominal or pelvic surgery; alcohol dependence; nicotine or drugs,; metallic implant; pacemaker; and chronic urinary tract disease
Exclusion criteria
Exclusion criteria: Severe headache in more than two transcranial stimulation sessions; dizziness or severe migraine in more than two transcranial stimulation sessions; failure to perform 2 or more transcranial stimulation applications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find a moderate improvement of 30% to 50% in pain determined through the visual analogue scale. Data collected one week before the intervention, at the end of the intervention and with a 30-day follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected to find moderate improvement in pressure pain threshold and tolerance using a pressure algometer;It is expected to find a moderate improvement of 30% to 50% in the intensity and interference of pain in the lives of volunteers through the pain inventory. Data collected one week before the intervention, at the end of the intervention and with a 30-day follow-up;It is expected a slight improvement in the submaximal functional capacity assessed through the 6-minute walk test is expected. Data collected one week before the intervention, at the end of the intervention and with a 30-day follow-up;It is expected a slight improvement of up to 20% is expected in lower limb strength according to the 30-second sit-to-stand test. Data collected one week before the intervention, at the end of the intervention and with a 30-day follow-up;It is expected a slight improvement of up to 20% in power, speed, agility and dynamic balance is expected according to the Timed Up and Go test. Data collected one week before the intervention, at the end of the intervention and with a 30-day follow-up;It is expected a moderate improvement of up to 30% is expected in quality of life assessed by the short version of the World Health Organization Quality of Life questionnaire. Data collected one week before the intervention, at the end of the intervention and with a 30-day follow-up;A moderate improvement of up to 30% is expected in positive and negative affect assessed by the affect scale. Data collected one week before the intervention, at the end of the intervention and with a 30-day follow-up;A moderate improvement of up to 30% is expected in anxiety measured according to the Hamilton Anxiety Scale. Data collected one week before the intervention, at the end of the intervention and with a 30-day follow-up;A moderate improvement of up to 30% is expected in depression measured according to the Beck Depression Scale. Data collected one week before the intervention, at the end of the interv | — |
Countries
Brazil
Contacts
Public ContactRodrigo Freitas
Universidade Federal do Rio Grande do Norte
Outcome results
None listed